Monopar Therapeutics
MNPR
MNPR
4 hedge funds and large institutions have $439K invested in Monopar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
4
Holders Change
+4
Holders Change %
–
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Bank of Montreal
Toronto,
Ontario, Canada
|
$216K |
| 2 |
2
Morgan Stanley
New York
|
$177K |
| 3 |
PCM
3
Prelude Capital Management
New York
|
$25K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$21K |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Bank of Montreal
Toronto,
Ontario, Canada
| $216K | 13,000 | +13,000 | New |
|
|
2
Morgan Stanley
New York
| $177K | 10,632 | +10,632 | New |
|
|
PCM
3
Prelude Capital Management
New York
| $25K | 1,510 | +1,510 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $21K | 1,290 | +1,290 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|